Pharmaceutical Collaborative Robots Market to Grow with a CAGR of 9.17% through 2028
The quest for superior product quality and the
ever-present challenge of skilled labor shortages is expected to drive the
Global Pharmaceutical Collaborative Robots Market growth in the forecast
period, 2024-2028.
According to TechSci Research report, “Pharmaceutical
Collaborative Robots Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Pharmaceutical
Collaborative Robots Market stood at USD 64.60 million in 2022 and is
anticipated to grow with a CAGR of 9.17% in the forecast period, 2024-2028.
This can be attributed to flexibility and scalability. Pharmaceutical
manufacturers often face fluctuations in demand. Collaborative robots offer
flexibility and scalability, allowing companies to quickly adapt to changing
production requirements. This adaptability is particularly advantageous in a
market where the need for agile manufacturing is essential.
Furthermore, the integration of the Internet of Things
(IoT) in collaborative robots will enable remote monitoring and predictive
maintenance. Pharmaceutical manufacturers can track the performance of their
cobots in real-time, allowing for proactive maintenance to prevent unexpected
downtime and ensure continuous operation.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Pharmaceutical Collaborative Robots Market”
Collaborative robots, often known as cobots, are
advanced robotic systems specifically designed for cooperative work with humans
within shared workspaces. In contrast to conventional industrial robots that
typically operate in isolated environments, cobots come equipped with sensors,
safety features, and user-friendly interfaces, enabling safe and efficient
interactions with human workers. In the healthcare sector, especially within
pharmaceutical settings, cobots are increasingly being deployed for various
tasks due to their precision, adaptability, and ability to work alongside human
operators. In pharmaceutical laboratories, cobots represent sophisticated
robotic systems tailored for seamless and collaborative interaction with human
workers. Their adaptability and aptitude for close cooperation with humans have
made them increasingly popular in the pharmaceutical industry.
The primary advantage of utilizing cobots in the
pharmaceutical sector is their ability to augment human labor, resulting in
increased efficiency and productivity in production processes. By integrating
cobots into their operations, pharmaceutical companies can accelerate
production timelines and boost output while maintaining strict product quality
standards. Furthermore, cobots have the potential to enhance worker safety by
taking on hazardous and repetitive tasks that might otherwise put human personnel
at risk. The global pandemic disrupted supply chains, potentially impacting the
availability of pharmaceutical ingredients. Cobots, with their material
handling capabilities, played a vital role in sustaining manufacturing and
distribution. To comply with safety measures such as social distancing,
pharmaceutical companies turned to cobots to ensure worker safety while
sustaining operational efficiency.
The heightened demand for medical supplies compelled
pharmaceutical companies to employ cobots for rapidly scaling up production to
meet urgent healthcare needs. During workforce shortages caused by lockdowns,
cobots handled routine tasks, allowing remote human workers to focus on
critical production aspects. Cobots' precision in handling and sensing
capabilities facilitated COVID-19 research, aiding accurate experimentation and
sample handling. The rapid evolution of technology has had a profound impact on
various industries, with the pharmaceutical sector being no exception.
Adaptability to emerging technologies is crucial in this sector, and cobots
exemplify a transformative development that is reshaping pharmaceutical
competitiveness and innovation. Cobots have undergone significant enhancements
in terms of their capabilities, functionality, and user-friendliness, driven by
ongoing research and development efforts.
These advancements, powered by artificial
intelligence, machine learning, sensors, and advanced control algorithms,
empower cobots to perform intricate tasks with precision. Furthermore, improved
user interfaces make automation more accessible, enabling a wider range of
employees to effectively optimize processes. Despite the numerous advantages
that cobots offer in the pharmaceutical industry, there are several key
barriers to their widespread adoption. The initial investment cost can be
substantial, including the expenses related to purchasing and integrating
cobots, as well as training personnel for their operation. Additionally, cobots
must adhere to stringent regulatory standards in the pharmaceutical sector,
necessitating comprehensive validation processes and documentation to ensure
compliance with safety and quality requirements, which can extend
implementation timelines.
The Global Pharmaceutical Collaborative Robots Market
is segmented into application, end-use, regional distribution, and company.
Based on its application, the picking and packaging
sector asserted its supremacy in the market by securing the largest market
share in 2022. This achievement can be attributed to the pivotal role this
segment plays in the supply chain and manufacturing processes. Picking and packaging
operations are instrumental in efficiently organizing, preparing, and
dispatching products. Given the rising demand for streamlined logistics, the
rapid growth of e-commerce, and the necessity for precision in delivering products
to consumers, companies are giving high priority to automation solutions in
these areas.
Consequently, investments in collaborative robots for
picking and packaging have witnessed a remarkable surge, strengthening the
segment's dominance in the 2022 market. Moreover, this segment is anticipated
to experience the swiftest growth with a CAGR during the forecast period. This
growth can be attributed to the capability of robots to enhance precision and
efficiency while addressing complex material handling challenges. Furthermore,
the pick-and-place approach offers these advantages while conserving floor
space by operating within a limited work area, effectively optimizing workspace
utilization. This trend reflects the industry's commitment to maximizing
operational efficiency while ensuring efficient use of available space.
Based on end-use, the pharmaceutical companies sector
emerged as the dominant force in the market by securing the largest market
share in 2022. This trend can be attributed to the increasing adoption of
robotics in drug discovery and development. Additionally, the growth of this
segment was fueled by pharmaceutical firms' active involvement in personalized
medicine initiatives.
During the projected period, research laboratories are
expected to undergo significant expansion, primarily due to the capacity of
automation to handle repetitive tasks, such as the transfer of test tubes and
fluids, in drug discovery endeavors. This automation enhances precision and
consistency in these critical processes.
Moreover, this segment is anticipated to experience
the most rapid growth with a CAGR during the forecast period. The industry's
steadfast commitment to research and development ensures a continuous stream of
improved products, further solidifying its position in the market. Meeting
stringent regulatory standards for safety and efficacy also adds to the
credibility of pharmaceutical offerings.
Major companies operating in Global Pharmaceutical
Collaborative Robots Market are:
- ABB Limited
- Universal Robots A/S
- Mitsubishi Electric Corp
- KUKA AG
- Kawasaki Heavy Industries Ltd
- YASKAWA Electric Corporation
- Denso Wave Inc
- Fanuc America Corp
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“The global pharmaceutical collaborative robots market
is witnessing a transformative shift as it adapts to the ever-evolving
landscape of the pharmaceutical industry. Pharmaceutical manufacturers are
embracing the upcoming key trends to address challenges related to efficiency,
quality, and flexibility while staying compliant with strict regulations. As
technology continues to advance and market demands change, the pharmaceutical
collaborative robots market is poised to remain at the forefront of innovation,
enabling the industry to meet the increasing global demand for safe and
effective pharmaceutical products,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Global Pharmaceutical Collaborative Robots Market By Application
(Picking and Packaging, Inspection of Pharmaceutical Drugs, Laboratory
Applications), By End-use (Pharmaceutical Companies, Research Laboratories,
Others), By Region, By
Competition Forecast & Opportunities, 2018-2028F”, has evaluated
the future growth potential of Global Pharmaceutical Collaborative Robots Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Pharmaceutical Collaborative Robots Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel:
+13322586602
Email:
[email protected]
Website:
www.techsciresearch.com